Evidence map›Paper›PMID 36613609›Full record

ArticleInternational journal of molecular sciences2022

Presence of Ceramidase Activity in Electronegative LDL.

Núria Puig, Jose Rives, Montserrat Estruch, Ana Aguilera-Simon, Noemi Rotllan, Mercedes Camacho, Núria Colomé, Francesc Canals, José Luis Sánchez-Quesada, Sonia Benitez

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Can Electronegative LDL Act as a Multienzymatic Complex?International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Núria PuigCardiovascular Biochemistry Group, Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Jose RivesCardiovascular Biochemistry Group, Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Montserrat EstruchBiotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen BRIC, DK-1350 Copenhagen, Denmark.
Ana Aguilera-SimonVascular Brain Diseases, IIB Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0003-1428-8212
Noemi RotllanMolecular Basis of Cardiovascular Risk, IIB Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0002-0587-8045
Mercedes CamachoGenomics of Complex Diseases Unit, IIB Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0001-5970-3294
Núria ColoméProteomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
Francesc CanalsProteomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
José Luis Sánchez-QuesadaCardiovascular Biochemistry Group, Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-0224-591X
Sonia BenitezCardiovascular Biochemistry Group, Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-3565-0743

Funding

Instituto de Salud Carlos III PI13/00364, PI16/00471, FIS PI019/00421, PI20/00334, FI20/00252, CB07/08/0016, CB16/11/00257
6 · The paper itself

Abstract

Electronegative low-density lipoprotein (LDL(-)) is a minor modified fraction of human plasma LDL with several atherogenic properties. Among them is increased bioactive lipid mediator content, such as lysophosphatidylcholine (LPC), non-esterified fatty acids (NEFA), ceramide (Cer), and sphingosine (Sph), which are related to the presence of some phospholipolytic activities, including platelet-activating factor acetylhydrolase (PAF-AH), phospholipase C (PLC), and sphingomyelinase (SMase), in LDL(-). However, these enzymes' activities do not explain the increased Sph content, which typically derives from Cer degradation. In the present study, we analyzed the putative presence of ceramidase (CDase) activity, which could explain the increased Sph content. Thin layer chromatography (TLC) and lipidomic analysis showed that Cer, Sph, and NEFA spontaneously increased in LDL(-) incubated alone at 37 °C, in contrast with native LDL(+). An inhibitor of neutral CDase prevented the formation of Sph and, in turn, increased Cer content in LDL(-). In addition, LDL(-) efficiently degraded fluorescently labeled Cer (NBD-Cer) to form Sph and NEFA. These observations defend the existence of the CDase-like activity's association with LDL(-). However, neither the proteomic analysis nor the Western blot detected the presence of an enzyme with known CDase activity. Further studies are thus warranted to define the origin of the CDase-like activity detected in LDL(-).

Indexed as

Fatty Acids, NonesterifiedProteomicsCeramidasesHumansLipoproteins, LDLLysophosphatidylcholinesSphingosineCeramidasesFatty Acids, NonesterifiedLipoproteins, LDLLysophosphatidylcholinesSphingosineceramidaseceramideelectronegative LDLsphingomyelinasesphingosine

Identifiers

PMID36613609
PMCPMC9820682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.